According to Bloomberg, NewLimit, a longevity startup founded by Coinbase co-founder Brian Armstrong, has raised $130 million in a Series B round, valuing the company at $810 million. The round was led by Kleiner Perkins, with participation from Khosla Ventures and Human Capital. NewLimit aims to delay aging and restore cellular function by reprogramming specific proteins within human cells. https://t.co/Lv70U9AxBK